In the BioHarmony Drug Report Database

"Preview" Icon

Axicabtagene ciloleucel

Yescarta (axicabtagene ciloleucel) is a gene pharmaceutical. Axicabtagene ciloleucel was first approved as Yescarta on 2017-10-18. It has been approved in Europe to treat follicular lymphoma and large b-cell lymphoma diffuse.

 

Trade Name

 

Yescarta
 

Common Name

 

axicabtagene ciloleucel
 

ChEMBL ID

 

CHEMBL3989989
 

Indication

 

follicular lymphoma, large b-cell lymphoma diffuse
 

Drug Class

 

Image (chem structure or protein)

Axicabtagene ciloleucel structure rendering